Literature DB >> 20222725

Therapeutic levels of levonorgestrel detected in blood plasma of fish: results from screening rainbow trout exposed to treated sewage effluents.

Jerker Fick1, Richard H Lindberg, Jari Parkkonen, Björn Arvidsson, Mats Tysklind, D G Joakim Larsson.   

Abstract

Pharmaceuticals are found in surface waters worldwide, raising concerns about effects on aquatic organisms. Analyses of pharmaceuticals in blood plasma of fish could provide means to assess risk for pharmacological effects, as these concentrations could be compared with available human therapeutic plasma levels. In this study we investigated if fish exposed to sewage effluents have plasma concentrations of pharmaceuticals that are approaching human therapeutic levels. We also evaluated how well the bioconcentration of pharmaceuticals into fish blood plasma can be predicted based on lipophilicity. Rainbow trout were exposed to undiluted, treated sewage effluents at three sites in Sweden for 14 days. Levels of 25 pharmaceuticals in blood plasma and effluents were analyzed with liquid chromatography-mass spectrometry/mass spectrometry and gas chromatography-high resolution mass spectrometry. The progestin pharmaceutical levonorgestrel was detected in fish blood plasma at concentrations (8.5-12 ng mL(-1)), exceeding the human therapeutic plasma level. In total 16 pharmaceuticals were detected in fish plasma at concentrations higher than 1/1000 of the human therapeutic plasma concentration. Twenty-one pharmaceuticals were detected in either plasma or effluent, and 14 were detected in both compartments, allowing plasma bioconcentration factors to be determined. For 11 of these, theoretically calculated and experimentally measured values were in reasonably good agreement. However a few drugs, including levonorgestrel, did not bioconcentrate according to the screening model used. This study shows that rainbow trout exposed to sewage effluents have blood plasma levels of pharmaceuticals similar to human therapeutic concentrations, suggesting a risk for pharmacological effects in the fish. There is a particular concern about effects of progestin pharmaceuticals. For levonorgestrel, the measured effluent level (1 ng/L) was higher than water levels shown to reduce the fertility of fish.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20222725     DOI: 10.1021/es903440m

Source DB:  PubMed          Journal:  Environ Sci Technol        ISSN: 0013-936X            Impact factor:   9.028


  21 in total

1.  An assessment of endocrine activity in Australian rivers using chemical and in vitro analyses.

Authors:  Philip D Scott; Michael Bartkow; Stephen J Blockwell; Heather M Coleman; Stuart J Khan; Richard Lim; James A McDonald; Helen Nice; Dayanthi Nugegoda; Vincent Pettigrove; Louis A Tremblay; Michael St J Warne; Frederic D L Leusch
Journal:  Environ Sci Pollut Res Int       Date:  2014-07-02       Impact factor: 4.223

Review 2.  Application of liquid chromatography-tandem mass spectrometry in quantitative bioanalyses of organic molecules in aquatic environment and organisms.

Authors:  Ugo Bussy; Ke Li; Weiming Li
Journal:  Environ Sci Pollut Res Int       Date:  2016-03-21       Impact factor: 4.223

3.  Human therapeutic plasma levels of the selective serotonin reuptake inhibitor (SSRI) sertraline decrease serotonin reuptake transporter binding and shelter-seeking behavior in adult male fathead minnows.

Authors:  Theodore W Valenti; Georgianna G Gould; Jason P Berninger; Kristin A Connors; N Bradley Keele; Krista N Prosser; Bryan W Brooks
Journal:  Environ Sci Technol       Date:  2012-02-07       Impact factor: 9.028

4.  Mianserin affects alarm reaction to conspecific chemical alarm cues in Nile tilapia.

Authors:  Rodrigo Egydio Barreto
Journal:  Fish Physiol Biochem       Date:  2016-08-23       Impact factor: 2.794

5.  Detection of naproxen and its metabolites in fish bile following intraperitoneal and aqueous exposure.

Authors:  Jenny-Maria Brozinski; Marja Lahti; Aimo Oikari; Leif Kronberg
Journal:  Environ Sci Pollut Res Int       Date:  2011-01-21       Impact factor: 4.223

6.  Bioaccumulation and trophic dilution of human pharmaceuticals across trophic positions of an effluent-dependent wadeable stream.

Authors:  Bowen Du; Samuel P Haddad; Andreas Luek; W Casan Scott; Gavin N Saari; Lauren A Kristofco; Kristin A Connors; Christopher Rash; Joseph B Rasmussen; C Kevin Chambliss; Bryan W Brooks
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-11-19       Impact factor: 6.237

7.  Determining potential adverse effects in marine fish exposed to pharmaceuticals and personal care products with the fish plasma model and whole-body tissue concentrations.

Authors:  James P Meador; Andrew Yeh; Evan P Gallagher
Journal:  Environ Pollut       Date:  2017-07-26       Impact factor: 8.071

Review 8.  Endocrine disruptors of sex hormone activities.

Authors:  L Varticovski; D A Stavreva; A McGowan; R Raziuddin; G L Hager
Journal:  Mol Cell Endocrinol       Date:  2021-07-30       Impact factor: 4.102

9.  Implementing ecopharmacovigilance in practice: challenges and potential opportunities.

Authors:  Gisela Holm; Jason R Snape; Richard Murray-Smith; John Talbot; David Taylor; Pernilla Sörme
Journal:  Drug Saf       Date:  2013-07       Impact factor: 5.606

10.  The read-across hypothesis and environmental risk assessment of pharmaceuticals.

Authors:  Mariann Rand-Weaver; Luigi Margiotta-Casaluci; Alpa Patel; Grace H Panter; Stewart F Owen; John P Sumpter
Journal:  Environ Sci Technol       Date:  2013-09-30       Impact factor: 9.028

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.